Literature DB >> 27553389

Monosegmental vs bisegmental pedicle fixation for the treatment of thoracolumbar spine fractures.

Giovanni Andrea La Maida1, Francesco Luceri2, Marcello Ferraro1, Carlo Ruosi3, Giuseppe Vincenzo Mineo4, Bernardo Misaggi1.   

Abstract

INTRODUCTION: The anatomy and biomechanics of the thoracolumbar spine place these segments at high risk of trauma injuries. Treatment options are either conservative or surgical, and there is a lack of consensus about the right indications. International scientific publications agree only on basic surgical principles: vertebral stability, deformity correction, protection of neurological structures and fast functional recovery. The most commonly used approach is the posterior approach, which allows the best management of most vertebral fracture patterns. The aim of this study was to compare clinical and radiological outcomes of monosegmental stabilisation with those of bisegmental stabilisation and fusion in the treatment of traumatic thoracolumbar spine fractures.
MATERIALS AND METHODS: This retrospective clinical and radiological study evaluated 48 consecutive patients treated with monosegmental (Group M; n=14) or bisegmental (Group B; n=34) posterior pedicular instrumentation for thoracolumbar fractures. Fractures were classified by the new AO Spine TLIC system. Average follow-up was 30 months. Clinical outcomes in both groups were statistically compared. Radiological outcomes were evaluated in terms of vertebral anterior body height restoration and correction of the kyphotic deformity.
RESULTS: Radiographical results showed no statistically significant difference between the two groups in vertebral body height restoration and correction of the kyphotic deformity. The mean postoperative somatic vertebral anterior body height in Group M was 25.8±4.52mm and in Group B it was 24.43±4.27mm. In Group M the mean postoperative kyphotic deformity was 11.10±5.71°, in Group B it was 9.09±4.93°.
CONCLUSIONS: The results of this study confirm the validity of short and very short instrumentation for the treatment of well-selected type A and B vertebral fractures. In C type fractures correct surgical indication must be evaluated on an individual basis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Thoracolumbar fractures; bisegmental stabilisation; monosegmental stabilisation; short fusion

Mesh:

Year:  2016        PMID: 27553389     DOI: 10.1016/j.injury.2016.07.052

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Indications for the monosegmental stabilization of thoraco-lumbar spine fractures.

Authors:  Giovanni Andrea La Maida; Carlo Ruosi; Bernardo Misaggi
Journal:  Int Orthop       Date:  2018-11-14       Impact factor: 3.075

2.  Monosegmental anterior column reconstruction using an expandable vertebral body replacement device in combined posterior-anterior stabilization of thoracolumbar burst fractures.

Authors:  Richard A Lindtner; Max Mueller; Rene Schmid; Anna Spicher; Michael Zegg; Christian Kammerlander; Dietmar Krappinger
Journal:  Arch Orthop Trauma Surg       Date:  2018-04-06       Impact factor: 3.067

3.  Treatment of Fractures of the Thoracolumbar Spine: Recommendations of the Spine Section of the German Society for Orthopaedics and Trauma (DGOU).

Authors:  Akhil P Verheyden; Ulrich J Spiegl; Helmut Ekkerlein; Erol Gercek; Stefan Hauck; Christoph Josten; Frank Kandziora; Sebastian Katscher; Philipp Kobbe; Christian Knop; Wolfgang Lehmann; Rainer H Meffert; Christian W Müller; Axel Partenheimer; Christian Schinkel; Philipp Schleicher; Matti Scholz; Christoph Ulrich; Alexander Hoelzl
Journal:  Global Spine J       Date:  2018-09-07

4.  One-stage posterior debridement, bone grafting fusion, and mono-segment vs. short-segment fixation for single-segment lumbar spinal tuberculosis: minimum 5-year follow-up outcomes.

Authors:  Zheng Liu; Weiwei Li; Zhengchao Xu; Xiyang Wang; Hao Zeng
Journal:  BMC Musculoskelet Disord       Date:  2020-02-07       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.